BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 920242)

  • 21. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
    Shimon I; Cohen O; Lubetsky A; Olchovsky D
    Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TSH as an index of L-thyroxine replacement and suppression therapy.
    Igoe D; Duffy MJ; McKenna TJ
    Ir J Med Sci; 1992 Dec; 161(12):684-6. PubMed ID: 1366242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal thyrotrophin response to intravenous thyrotrophin releasing hormone administration: the best index of optimal L-thyroxine therapy in primary hypothyroidism.
    Kabadi UM
    Postgrad Med J; 1985 Aug; 61(718):685-8. PubMed ID: 3929241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of free thyroxine (FT4), free triiodothyronine (FT3), and sensitive thyrotropin (TSH) assay in the assessment of optimal thyroxine therapy.
    Kalra J; Hart IR
    Clin Biochem; 1987 Aug; 20(4):265-7. PubMed ID: 3690828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine?
    Cassio A; Cacciari E; Cicognani A; Damiani G; Missiroli G; Corbelli E; Balsamo A; Bal M; Gualandi S
    Pediatrics; 2003 May; 111(5 Pt 1):1055-60. PubMed ID: 12728088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children.
    Rezvani I; DiGeorge AM
    J Pediatr; 1977 Feb; 90(2):291-7. PubMed ID: 830925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.
    Sato T; Suzuki Y; Taketani T; Ishiguro K; Nakajima H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):553-9. PubMed ID: 402383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations.
    Woeber KA
    J Endocrinol Invest; 2002 Feb; 25(2):106-9. PubMed ID: 11929079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.
    Soppi E; Irjala K; Kaihola HL; Viikari J
    Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diurnal variation in TSH and free thyroid hormones in patients on thyroxine replacement.
    Sturgess I; Thomas SH; Pennell DJ; Mitchell D; Croft DN
    Acta Endocrinol (Copenh); 1989 Nov; 121(5):674-6. PubMed ID: 2588938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimum replacement dose of thyroid hormone assessed by highly sensitive TSH determination in patients with congenital hypothyroidism.
    Sato H; Inomata H; Sasaki N; Niimi H; Nakajima H
    Endocrinol Jpn; 1988 Aug; 35(4):531-6. PubMed ID: 3215142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement.
    Gow SM; Caldwell G; Toft AD; Seth J; Hussey AJ; Sweeting VM; Beckett GJ
    J Clin Endocrinol Metab; 1987 Feb; 64(2):364-70. PubMed ID: 3793854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free thyroid hormones in evaluating persistently elevated thyrotropin levels in children with congenital hypothyroidism on replacement therapy.
    Focarile F; Rondanini GF; Bollati A; Bartolucci A; Chiumello G
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1211-4. PubMed ID: 6490797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of L-thyroxine replacement.
    Burnett JR; Cooke R; Crooke MJ; Feek CM
    N Z Med J; 1992 Mar; 105(930):105-6. PubMed ID: 1553113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
    Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
    Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.
    Geffner DL; Azukizawa M; Hershman JM
    J Clin Invest; 1975 Feb; 55(2):224-9. PubMed ID: 805160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
    Frey HM; Haug E
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between levels of thyroid stimulating hormone and of thyroxine and triiodothyronine in blood of hypothyroid patients.
    Johansen K; Hansen JM; Skovsted L
    Acta Endocrinol (Copenh); 1978 Aug; 88(4):691-7. PubMed ID: 581111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay.
    Spencer CA; Lai-Rosenfeld AO; Guttler RB; LoPresti J; Marcus AO; Nimalasuriya A; Eigen A; Doss RC; Green BJ; Nicoloff JT
    J Clin Endocrinol Metab; 1986 Aug; 63(2):349-55. PubMed ID: 3088021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.